Clinical Trials Directory

Trials / Conditions / Siewert Type II Adenocarcinoma of Esophagogastric Junction

Siewert Type II Adenocarcinoma of Esophagogastric Junction

8 registered clinical trials studyying Siewert Type II Adenocarcinoma of Esophagogastric Junction — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric
NCT07441785
P. Herzen Moscow Oncology Research Institute—
RecruitingOral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
NCT06044311
Sakti ChakrabartiPhase 2
RecruitingRight Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
NCT06644352
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
RecruitingComparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
NCT05356520
Xijing Hospital of Digestive DiseasesN/A
UnknownClassification of Adenocarcinoma of the Esophagogastric Junction
NCT04151524
St. James's Hospital, Ireland—
UnknownA Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewer
NCT04423354
Guangdong Provincial Hospital of Traditional Chinese MedicineN/A
UnknownLength of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors
NCT02313688
West China HospitalN/A
CompletedSiewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival
NCT03416101
University of Bologna—